Systems-Mapping of Herbal Effects on Complex Diseases Using the Network-Perturbation Signatures

The herbs have proven to hold great potential to improve people's health and wellness during clinical practice over the past millennia. However, herbal medicine for the personalized treatment of disease is still under investigation owing to the complex multi-component interactions in herbs. To reveal the valuable insights for herbal synergistic therapy, we have chosen Traditional Chinese Medicine (TCM) as a case to illustrate the art and science behind the complicated multi-molecular, multi-genes interaction systems, and how the good practices of herbal combination therapy are applicable to personalized treatment. Here, we design system-wide interaction map strategy to provide a generic solution to establish the links between diseases and herbs based on comprehensive testing of molecular signatures in herb-disease pairs. Firstly, we integrated gene expression profiles from 189 diseases to characterize the disease-pathological feature. Then, we generated the perturbation signatures from the huge chemical informatics data and pharmacological data for each herb, which were represented the targets affected by the ingredients in the herb. So that we could assess the effects of herbs on the individual. Finally, we integrated the data of 189 diseases and 502 herbs, yielding the optimal herbal combinations for the diseases based on the strategy, and verifying the reliability of the strategy through the permutation testing and literature verification. Furthermore, we propose a novel formula as a candidate therapeutic drugs of rheumatoid arthritis and demonstrate its therapeutic mechanism through the systematic analysis of the influencing targets and biological processes. Overall, this computational method provides a systematic approach, which blended herbal medicine and omics data sets, allowing for the development of novel drug combinations for complex human diseases.

[1]  S. Wachtel-Galor,et al.  Herbal Medicine: Biomolecular and Clinical Aspects , 2011 .

[2]  Xi-jun Wang,et al.  Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. , 2012, Complementary therapies in medicine.

[3]  T. Efferth,et al.  Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. , 2011, Current drug targets.

[4]  J. Smolen,et al.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges , 2015, Nature Reviews Rheumatology.

[5]  Yang Liu,et al.  Inferring Infection Patterns Based on a Connectivity Map of Host Transcriptional Responses , 2015, Scientific Reports.

[6]  L. Klareskog,et al.  Mechanisms involved in triggering rheumatoid arthritis , 2016, Immunological reviews.

[7]  C. Grossman Interactions between the gonadal steroids and the immune system. , 1985, Science.

[8]  H. Zhan,et al.  Traditional Chinese Herbal Patch for Short-Term Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial , 2012, Evidence-based complementary and alternative medicine : eCAM.

[9]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[10]  D. Tripathy,et al.  Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. , 2007, The Cochrane database of systematic reviews.

[11]  Kelvin Chan,et al.  An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. , 2012, Journal of ethnopharmacology.

[12]  Oliver Werz,et al.  Multi-target approach for natural products in inflammation. , 2014, Drug discovery today.

[13]  P. Shenefelt Herbal Treatment for Dermatologic Disorders , 2011 .

[14]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[15]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[16]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[17]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[18]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[19]  E. Sugaya,et al.  Radical scavenger effect of Boschniakia rossica. , 1994, Journal of ethnopharmacology.

[20]  Raveendhara R. Bannuru,et al.  American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2015 .

[21]  Robert C. Green,et al.  Variations in predicted risks in personal genome testing for common complex diseases , 2013, Genetics in Medicine.

[22]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[23]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[24]  Robert V Farese,et al.  DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. , 2010, The Journal of clinical investigation.

[25]  D. Kleinjan,et al.  Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.

[26]  G. Burmester,et al.  Exogenous and endogenous glucocorticoids in rheumatic diseases. , 2011, Arthritis and rheumatism.

[27]  J. Meigs,et al.  Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories , 2018, Hypertension.

[28]  Mi‐Sun Kim,et al.  Inhibitory effects of Cimicifugae rhizoma extracts on histamine, bradykinin and COX‐2 mediated inflammatory actions , 2000, Phytotherapy research : PTR.

[29]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[30]  A. Drosos,et al.  Epidemiology of adult rheumatoid arthritis. , 2005, Autoimmunity reviews.

[31]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[32]  Justin Lamb,et al.  The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.

[33]  Hongbin Sun,et al.  Synthesis, Biology and Clinical Significance of Pentacyclic Triterpenes: A Multi‐Target Approach to Prevention and Treatment of Metabolic and Vascular Diseases , 2011 .

[34]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[35]  Syed Mohsin,et al.  Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.

[36]  J. Mullins,et al.  Mineralocorticoid excess or glucocorticoid insufficiency: renal and metabolic phenotypes in a rat Hsd11b2 knockout model. , 2015, Hypertension.

[37]  S. Ignatova,et al.  Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. , 2012, Journal of ethnopharmacology.

[38]  Joel T Dudley,et al.  Mapping the effects of drugs on the immune system , 2015, Nature Biotechnology.

[39]  Thomas Pap,et al.  Cartilage damage in osteoarthritis and rheumatoid arthritis—two unequal siblings , 2015, Nature Reviews Rheumatology.

[40]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[41]  Xi-jun Wang,et al.  Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. , 2011, Journal of pharmaceutical and biomedical analysis.

[42]  J. Mullins,et al.  Mineralocorticoid Excess or Glucocorticoid Insufficiency , 2015, Hypertension.

[43]  Zijian Li,et al.  A novel drug discovery strategy inspired by traditional medicine philosophies , 2015 .

[44]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[45]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[46]  Xiaojuan He,et al.  Drug discovery in traditional Chinese medicine: From herbal fufang to combinatory drugs , 2015 .

[47]  F. Sams-Dodd Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[48]  W. Shen,et al.  LC-MS/MS analysis and evaluation of the anti-inflammatory activity of components from BushenHuoxue decoction , 2017, Pharmaceutical biology.

[49]  F. Klebl,et al.  Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study , 2003, Alimentary pharmacology & therapeutics.

[50]  María Rodríguez Martínez,et al.  Elucidating Compound Mechanism of Action by Network Perturbation Analysis Graphical , 2015 .

[51]  G. Kitas,et al.  Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. , 2010, Antioxidants & redox signaling.

[52]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[53]  Yonghua Wang,et al.  Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM , 2015, Evidence-based complementary and alternative medicine : eCAM.

[54]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[55]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[56]  K. Chapman,et al.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights , 2011, Molecular and Cellular Endocrinology.

[57]  J. Pei,et al.  Purification and physicochemical properties of different polysaccharide fractions from the water extract of Boschniakia rossica and their effect on macrophages activation. , 2011, International journal of biological macromolecules.

[58]  Jun-Beom Park,et al.  Effects of Cimicifugae Rhizoma on the osteogenic and adipogenic differentiation of stem cells , 2016, Experimental and therapeutic medicine.

[59]  Laleh Soltan Ghoraie,et al.  A review of connectivity map and computational approaches in pharmacogenomics , 2017, Briefings Bioinform..

[60]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[61]  John D. Isaacs,et al.  Cytokines in rheumatoid arthritis — shaping the immunological landscape , 2016, Nature Reviews Rheumatology.

[62]  E. Walters,et al.  Clinical relevance of airway 11beta-hydroxysteroid dehydrogenase type II enzyme in asthma. , 2002, American journal of respiratory and critical care medicine.

[63]  Raveendhara R. Bannuru,et al.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis care & research.

[64]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[65]  Xue-zhe Yin,et al.  Effect of Boschniakia rossica on expression of GST-P, p53 and p21(ras)proteins in early stage of chemical hepatocarcinogenesis and its anti-inflammatory activities in rats. , 2000, World journal of gastroenterology.

[66]  Chao Huang,et al.  Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..

[67]  H. Wiendl,et al.  Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous system , 2015, Acta Neuropathologica.

[68]  Yan Li,et al.  Large-scale Direct Targeting for Drug Repositioning and Discovery , 2015, Scientific Reports.

[69]  G. Firestein The disease formerly known as rheumatoid arthritis , 2014, Arthritis Research & Therapy.

[70]  Kalyanmoy Deb,et al.  A fast and elitist multiobjective genetic algorithm: NSGA-II , 2002, IEEE Trans. Evol. Comput..

[71]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..